Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-04-25 | 2019-05-28 | 82410 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86859 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86879 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106919 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-05-01 | 111803 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139728 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183380 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2023-11-30 | 2024-02-15 | 211973 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2024-06-13 | 2024-11-18 | 230316 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2024-06-20 | 2024-11-18 | 230967 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2025-08-14 | 2025-12-02 | 265217 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2020-02-21 | 2020-05-01 | 106931 |
| TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2020-03-12 | 2020-03-26 | 108593 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109586 |
| TEVA-CARVEDILOL | 12.5MG | TABLET | Resolved | 2020-06-04 | 2020-09-25 | 116687 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141107 |
| TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2022-06-16 | 2022-08-09 | 162852 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174598 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174601 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2024-05-09 | 2024-09-19 | 227471 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |